HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mark R Schleiss Selected Research

Proteins (Proteins, Gene)

2/2014Identification by mass spectrometry and immune response analysis of guinea pig cytomegalovirus (GPCMV) pentameric complex proteins GP129, 131 and 133.
12/2013An Attenuated CMV Vaccine with a Deletion in Tegument Protein GP83 (pp65 Homolog) Protects against Placental Infection and Improves Pregnancy Outcome in a Guinea Pig Challenge Model.
3/2007Preconceptual administration of an alphavirus replicon UL83 (pp65 homolog) vaccine induces humoral and cellular immunity and improves pregnancy outcome in the guinea pig model of congenital cytomegalovirus infection.
9/2006Protection against congenital cytomegalovirus (CMV) disease, conferred by a replication-disabled, bacterial artificial chromosome (BAC)-based DNA vaccine.
12/2003Preconception vaccination with a glycoprotein B (gB) DNA vaccine protects against cytomegalovirus (CMV) transmission in the guinea pig model of congenital CMV infection.
3/2003Cloning and expression of the guinea pig cytomegalovirus glycoprotein B (gB) in a recombinant baculovirus: utility for vaccine studies for the prevention of experimental infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mark R Schleiss Research Topics

Disease

48Infections
02/2024 - 03/2003
26Cytomegalovirus Infections (Inclusion Disease)
12/2021 - 12/2003
11Viremia
09/2023 - 01/2005
7Hearing Loss (Hearing Impairment)
08/2023 - 06/2006
4Reinfection
12/2021 - 01/2013
3Opportunistic Infections (Opportunistic Infection)
01/2023 - 03/2008
3Fetal Diseases (Embryopathy)
01/2018 - 03/2003
2Sensorineural Hearing Loss
08/2023 - 06/2004
2Disease Progression
08/2023 - 01/2022
2Meningitis
09/2022 - 03/2008
2Neoplasms (Cancer)
01/2020 - 03/2008
1Latent Infection
09/2023
1COVID-19
01/2023
1Post-Acute COVID-19 Syndrome
01/2023
1Cryptococcosis
01/2023
1Tuberculosis (Tuberculoses)
01/2023
1Pre-Eclampsia (Preeclampsia)
10/2022
1Meningeal Tuberculosis (Tuberculous Meningitis)
09/2022
1Cryptococcal Meningitis
09/2022
1Birth Weight (Birth Weights)
12/2021
1Aplastic Anemia (Anemia, Hypoplastic)
09/2021
1Cerebral Toxoplasmosis
09/2021
1Otitis Media
08/2021
1Cerebral Palsy (Spastic Diplegia)
01/2021
1Myocarditis (Carditis)
10/2020
1Chest Pain (Chest Pains)
10/2020
1Heart Block
10/2020
1Syncope (Fainting)
10/2020
1Brain Neoplasms (Brain Tumor)
01/2020
1Reactive Arthritis (Reiter Disease)
11/2019
1Craniofacial Abnormalities
12/2017
1Zika Virus Infection
01/2017
1Virus Diseases (Viral Diseases)
07/2015
1Communicable Diseases (Infectious Diseases)
06/2014
1Vesicular Stomatitis
11/2010
1Bacterial Meningitis
03/2008
1Human Influenza (Influenza)
03/2007
1Autoimmune Diseases (Autoimmune Disease)
12/2004
1Weight Gain
09/2003
1Herpesviridae Infections (Herpesvirus Infection)
05/2003

Drug/Important Bio-Agent (IBA)

43VaccinesIBA
01/2023 - 03/2003
14Antiviral Agents (Antivirals)IBA
08/2023 - 05/2003
9Glycoproteins (Glycoprotein)IBA
12/2021 - 03/2003
6Proteins (Proteins, Gene)FDA Link
02/2014 - 03/2003
4Subunit VaccinesIBA
12/2021 - 04/2004
4Anti-Bacterial Agents (Antibiotics)IBA
09/2021 - 03/2008
4Neutralizing AntibodiesIBA
06/2017 - 01/2013
4Ganciclovir (Cytovene)FDA LinkGeneric
05/2008 - 08/2002
3DNA (Deoxyribonucleic Acid)IBA
09/2023 - 09/2021
3Immunoglobulin G (IgG)IBA
10/2022 - 03/2011
3Immunoglobulins (Immunoglobulin)IBA
10/2022 - 10/2006
3Attenuated VaccinesIBA
12/2013 - 05/2008
2salicylhydroxamic acid (SHAM)IBA
12/2021 - 06/2006
2AntibodiesIBA
10/2020 - 06/2017
2AntigensIBA
01/2017 - 05/2014
2Simplexvirus glycoprotein BIBA
10/2016 - 12/2004
2Synthetic Vaccines (Recombinant Vaccines)IBA
02/2014 - 11/2010
2DNA VaccinesIBA
10/2009 - 12/2003
2Cidofovir (Vistide)FDA Link
06/2006 - 03/2006
2cyclic- 1- (3- hydroxy- 2- phosphonylmethoxypropyl)cytosineIBA
03/2006 - 09/2003
1InterferonsIBA
09/2023
1Biomarkers (Surrogate Marker)IBA
09/2022
1RNA (Ribonucleic Acid)IBA
01/2022
1AIDS VaccinesIBA
11/2021
1CytokinesIBA
01/2021
1GlobulinsIBA
12/2020
1Immunoglobulin M (IgM)IBA
10/2020
1ChemokinesIBA
01/2020
1Protein Kinases (Protein Kinase)IBA
10/2015
1EnzymesIBA
10/2015
1ImmunosorbentsIBA
10/2015
1Nucleic AcidsIBA
01/2015
1Freund's AdjuvantIBA
05/2014
1Recombinant ProteinsIBA
02/2014
1letermovirIBA
05/2013
1Viral VaccinesIBA
01/2013
1Membrane Glycoproteins (Membrane Glycoprotein)IBA
10/2009
1PhosphoproteinsIBA
10/2009
1Poloxamer (Poloxamer 407)IBA
10/2009
1Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA
10/2007
1Chemokine CCL3IBA
10/2007
1Hemagglutinins (Hemagglutinin)IBA
03/2007
1A-Form DNA (A-DNA)IBA
09/2006
1enhanced green fluorescent proteinIBA
03/2006
1Clindamycin (Cleocin)FDA LinkGeneric
09/2005
1Meropenem (Merrem)FDA LinkGeneric
09/2005
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2005
13- hydroxy- 2,2- dimethyl- N- (4(((5- (dimethylamino)- 1- naphthyl)sulfonyl)amino)phenyl)propanamideIBA
01/2005
1AutoantibodiesIBA
12/2004

Therapy/Procedure

20Therapeutics
02/2024 - 05/2003
2Art Therapy
09/2022 - 01/2022
2Injections
11/2013 - 10/2009
1Ambulatory Care (Outpatient Care)
02/2024
1Highly Active Antiretroviral Therapy (HAART)
01/2023
1Cell Transplantation
09/2021
1Middle Ear Ventilation (Tympanostomy)
08/2021
1Immunotherapy
01/2020
1Prenatal Care (Care, Prenatal)
01/2020
1Hematopoietic Stem Cell Transplantation
03/2008
1Aftercare (After-Treatment)
01/2005